Delivery Order W911QY08D0021-0008

The Defense Health Agency awarded a $11.6 million delivery order against its Medical Product Research and Development master IDIQ contract to PPD Development LP. This cost-plus-fixed-fee order is to provide clinical monitoring services for a Phase 2B proof of concept study being conducted in South Africa. The study aims to develop an HIV vaccine that meets the requirements of the U.S. Military. Performance will take place in South Africa over a five year period concluding in October 2022. No set...

This is a delivery order awarded by the U.S. Navy Bureau of Medicine and Surgery to Research Triangle Institute (RTI International), a non-profit research organization, under the Navy Medicine R&D Support Omnibus III indefinite delivery, indefinite quantity (IDIQ) contract. The $8,425,412.49 award is for scientific support services at the Naval Health Research Center in support of the Defense HIV/AIDS Prevention Program (DHAPP). The award does not have a set-aside designation. RTI...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services (HHS). The $128,312.76 cost-plus-fixed-fee contract was awarded to Southern Research Institute, a non-profit organization that provides research and development services, to develop new assays for HIV therapeutics and topical microbicides. The contract does not have a set-aside designation. Southern Research Institute...

This is a cost-plus-fixed-fee contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Southern Research Institute to provide "OTHER FUNCTIONS" PRIMATE MODELS TO EVALUATE HIV PREVENTION THERAPEUTIC STRATEGIES. The $2,023,097.35 contract has a period of performance through December 31, 2008 and does not utilize a set-aside. Southern Research Institute, a non-profit organization, has a history of...

This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Southern Research Institute, a non-profit research organization. The $257,889.11 cost-plus-fixed-fee contract is for the identification of anti-HIV lead compounds, which is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program. The contract has no set-aside designation and is a...

This delivery order, awarded August 15, 2012, represents a Cost Plus Fixed Fee task order modification under the Navy Medicine R&D Support Omnibus III (OMNIBUS III) contract vehicle. The modification transfers operational infectious disease surveillance and response work to the Naval Health Research Center (NHRC) in San Diego, California, with a ceiling value of approximately $5.9M and an ultimate completion date of August 15, 2014. The Henry M. Jackson Foundation for the Advancement of...

This is a cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency of the U.S. Department of Health and Human Services (HHS), to Southern Research Institute, a non-profit organization based in Birmingham, Alabama. The $99,998.00 contract requires Southern Research to acquire and store chemical compound libraries, and conduct high-throughput screening to identify and characterize at least one agent that can block HIV...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $75.2 million delivery order contract to PPD Development LP for Comprehensive and Rapid Response for NIAID Research Programs HIV and Other Infectious Diseases Clinical Research Support Services. This delivery order, issued on August 15, 2024, with an ultimate completion date of August 14, 2031, operates under a Cost Plus Fixed Fee pricing structure and does not utilize a set-aside designation. PPD Development LP, a...

This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the Department of Health and Human Services (HHS). The $496,282.56 cost-plus-fixed-fee contract was awarded to Southern Research Institute to identify anti-HIV therapeutics and topical microbicides through in vitro testing. The contract is part of NIAID's "In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides" program and does not have a...

Southern Research Institute was awarded a $749,998 cost-plus-fixed-fee delivery order against the In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides contract vehicle by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS). Under this delivery order, Southern Research will carry out activities to optimize, develop, and synthesize lead anti-HIV candidates and analogs, including resynthesis, acquisition, or...